Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
Cancer Treatment Reviews · 2024-02 · 123 · 102670
DOI: 10.1016/j.ctrv.2023.102670 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2024-02. Verfasst von Komal Jhaveri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, N…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Gilead Sciences Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA. Electronic address: jhaverik@mskcc.org.
- Gynecological Oncology Section, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Förderung
- Gilead Sciences Inc
Zitieren
APA
Jhaveri, K., & Marmé, F. (2024). Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. Cancer Treatment Reviews, 123, 102670. https://doi.org/10.1016/j.ctrv.2023.102670
Vancouver
Jhaveri K, Marmé F. Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. Cancer Treatment Reviews. 2024;123:102670. doi:10.1016/j.ctrv.2023.102670
BibTeX
@article{Jhaveri2024,
author = {Jhaveri, Komal and Marmé, Frederik},
title = {Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer},
journal = {Cancer Treatment Reviews},
year = {2024},
volume = {123},
pages = {102670},
doi = {10.1016/j.ctrv.2023.102670}
}
EUVIMED